Evidence map›Paper›PMID 40632155›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Design and characterization of SrO

Sanketsinh Thakore, Rajat Saini, Ravi Kant Kushwaha, Asha K, Indumathi Thangavelu, AbdulAziz A AlGhamdi, Srinivas Tadepalli

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sanketsinh ThakoreDepartment of Applied Science, PIT, Parul University, Vadodara, Gujarat, India.
Rajat SainiCentre of Research Impact and Outcome, Chitkara University, Rajpura, 140417, Punjab, India.
Ravi Kant KushwahaMaharishi School of Pharmaceutical Sciences, Maharishi University of Information Technology, Lucknow, Uttar Pradesh, India.
Asha KDepartment of Life Sciences, School of Sciences, JAIN (Deemed-to-be University), Bengaluru, Karnataka, India.
Indumathi ThangaveluDepartment of Chemistry, CHRIST (Deemed to be University), Bangalore, 560029, India.
AbdulAziz A AlGhamdiDepartment of Chemical Engineering, College of Engineering, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11432, Kingdom of Saudi Arabia.
Srinivas TadepalliDepartment of Chemical Engineering, College of Engineering, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11432, Kingdom of Saudi Arabia. stadepalli@imamu.edu.sa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HeLa cervical cancer cells exhibit high aggressiveness and proliferation, highlighting the need for novel therapies. Nanocomposite synthesis offers a promising approach due to its enhanced bioavailability, targeted delivery, and selective cytotoxicity. Thus, carboxymethyl cellulose (CMC) and D-carvone (Dcar)-coated strontium oxide (SrO

Indexed as

Anti-Infective AgentsAntineoplastic AgentsAntioxidantsCarboxymethylcellulose SodiumNanocompositesCell SurvivalHeLa CellsHumansMicrobial Sensitivity TestsAnti-Infective AgentsAntineoplastic AgentsAntioxidantsCarboxymethylcellulose SodiumAntibacterialAnticancerAntioxidantNanocompositeSrO₂-CMC-Dcar

Identifiers

PMID40632155

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.